导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -21.57% | 1011/1050 |
| 近一周 | -2.54% | 826/1104 |
| 近一月 | -9.98% | 1058/1103 |
| 近一季 | -24.93% | 1047/1092 |
| 近半年 | -24.38% | 1034/1070 |
| 近一年 | -21.37% | 921/1018 |
| 近两年 | 21.09% | 768/926 |
| 近三年 | 7.56% | 613/834 |
| 成立以来 | 200.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.34% 514/1070 |
3.66% 640/1101 |
- - |
- - |
| 2025 | 37.23% 365/1065 |
2.82% 560/1014 |
-0.89% 757/1038 |
46.95% 111/1050 |
-8.36% 840/1065 |
| 2024 | 10.02% 290/1011 |
6.48% 71/960 |
-2.50% 467/983 |
14.41% 266/991 |
-7.37% 795/1011 |
| 2023 | -29.36% 802/952 |
-7.55% 835/880 |
-2.18% 313/895 |
-14.27% 754/915 |
-8.89% 805/952 |
| 2022 | -24.58% 481/867 |
-16.72% 348/773 |
18.86% 32/806 |
-16.96% 681/845 |
-8.24% 741/867 |
| 2021 | 31.99% 61/740 |
-10.91% 508/580 |
33.21% 35/659 |
9.29% 76/704 |
1.77% 364/740 |
| 2020 | 125.66% 8/554 |
-5.65% 307/419 |
36.42% 53/466 |
25.28% 18/517 |
39.95% 12/554 |
| 2019 | 49.03% 156/410 |
27.00% 546/1146 |
-4.91% 706/1228 |
3.78% 225/390 |
18.93% 19/410 |
| 2018 | - - |
- - |
-7.31% 288/990 |
-7.40% 614/1000 |
-4.84% 53/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中欧先进制造股票A VS. 东吴新产业精选股票A(580008) |